The healthcare industry is a convergence of today's most pressing issues. Regulatory reform, technology, public and private partnerships are just some of the issues; chronic illness, ageing populations, cost control and the trend toward patient-centred care play key roles, too. Our healthcare publications keep you in the loop on all the trends shaping the industry, how they impact your organisation, and where the opportunities are for investment, innovation, cost-savings and growth.
On 7 June 2012, PwC will release a report about mobile health (mHealth) with analysis from the Economist Intelligence Unit. This report examines the development of mHealth in ten countries, five developed and five emerging, and the role that various stakeholders — from healthcare payers to physicians and patients — can play in its development.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 1Q 2012 edition focuses on investments in the evolving global hospital sector.
The fourth meeting in our series focused in particular on the challenges faced in emerging economies, highlighting innovative practices and solutions that are transferable from one healthcare system to the next. Healthcare executives and leaders from around the globe will gather in South Africa for this landmark event.
Healthcare CEOs are gloomy about the global economy, but they're diversifying and expanding overseas, showing a more positive outlook for their own organisations.
South East Asia’s evolving health systems are using healthcare public-private partnerships (PPPs) to expand capacity and quality of healthcare in emerging markets.
How we assess value in medical technology is changing. How can countries overcome their weaknesses to develop a system to help medical technology companies thrive?
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? This issue focuses on three compelling investment opportunities across the global healthcare provider market.
How can government and private industry be more accountable for healthcare delivery and financing, and how can they achieve greater efficiency in health spending?
On 15 November, 2011, PwC, in conjunction with sponsoring organisations – Duke-NUS Graduate Medical School Singapore, McGill University and The Nuffield Trust – convened the third in a series of four symposia called Bending the Cost Curve: Emerging International Best Practices.
In partnership with the European Hospital and Healthcare Federation (HOPE), this report explores the strategies European hospitals are undertaking to adapt as health systems shift toward more personalised health delivery and medicine.
PwC, in collaboration with McGill University and The Nuffield Trust, hosted the second symposium of Bending the Cost Curve in Amsterdam. About 30 European healthcare leaders participated in roundtable discussions exploring case studies in: wiring-up healthcare; integrated care; precision medicine; hospital efficiency and regulation of healthcare.
To take advantage of the opportunities that healthcare's new products and services offer, businesses need to build innovative business models to provide value.
On 2 February 2011, PwC, in conjunction with three sponsoring organizations—the Atlantic Council, McGill University and The Commonwealth Fund—launched Bending the Cost Curve: Emerging International Best Practices. The meeting brought together some of the world’s leading healthcare experts who explored five international case studies, debated the issues and left with lessons learned.
There is a major phenomenon in the Chinese healthcare marketplace: the explosion of a vigorous and demanding middle class. How does it impact the future directions the industry should pursue?
Mobile technology is changing the way we interact and communicate with each other, but it's yet to pierce the ingrained practices of healthcare. However, mobile health is making headway and creating business models that unlock access to new players and technologies that support preventative, acute and chronic care.
How universities manage innovation through disciplined and novel measures.
To survive the coming storm, biomedical companies must build new models of innovation that are anchored in consumer-centric disease solutions rather than the traditional R&D department approaches.
What are the emerging trends from the employer's perspective on the needs, wants, and satisfaction levels of employers regarding health insurance and benefits?
What is the capacity and capability for medical technology innovation in Brazil, China, France, Germany, India, Israel, Japan, United Kingdom, United States?
This report looks at the factors driving needed change in healthcare payment systems to meet future demands and leverage incentives to positively change behaviour and outcomes.
Healthcare services demand and expectations are rising. With reform on the agenda, PwC looks at the changing role of the health insurer.
On 7 June 2012, PwC will release a report about mobile health (mHealth) with analysis from the Economist Intelligence Unit. This report examines the development of mHealth in ten countries, five developed and five emerging, and the role that various stakeholders — from healthcare payers to physicians and patients — can play in its development.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 1Q 2012 edition focuses on investments in the evolving global hospital sector.
The fourth meeting in our series focused in particular on the challenges faced in emerging economies, highlighting innovative practices and solutions that are transferable from one healthcare system to the next. Healthcare executives and leaders from around the globe will gather in South Africa for this landmark event.
Healthcare CEOs are gloomy about the global economy, but they're diversifying and expanding overseas, showing a more positive outlook for their own organisations.
South East Asia’s evolving health systems are using healthcare public-private partnerships (PPPs) to expand capacity and quality of healthcare in emerging markets.
How we assess value in medical technology is changing. How can countries overcome their weaknesses to develop a system to help medical technology companies thrive?
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? This issue focuses on three compelling investment opportunities across the global healthcare provider market.
How can government and private industry be more accountable for healthcare delivery and financing, and how can they achieve greater efficiency in health spending?
On 15 November, 2011, PwC, in conjunction with sponsoring organisations – Duke-NUS Graduate Medical School Singapore, McGill University and The Nuffield Trust – convened the third in a series of four symposia called Bending the Cost Curve: Emerging International Best Practices.
In partnership with the European Hospital and Healthcare Federation (HOPE), this report explores the strategies European hospitals are undertaking to adapt as health systems shift toward more personalised health delivery and medicine.
PwC, in collaboration with McGill University and The Nuffield Trust, hosted the second symposium of Bending the Cost Curve in Amsterdam. About 30 European healthcare leaders participated in roundtable discussions exploring case studies in: wiring-up healthcare; integrated care; precision medicine; hospital efficiency and regulation of healthcare.
To take advantage of the opportunities that healthcare's new products and services offer, businesses need to build innovative business models to provide value.
On 2 February 2011, PwC, in conjunction with three sponsoring organizations—the Atlantic Council, McGill University and The Commonwealth Fund—launched Bending the Cost Curve: Emerging International Best Practices. The meeting brought together some of the world’s leading healthcare experts who explored five international case studies, debated the issues and left with lessons learned.
There is a major phenomenon in the Chinese healthcare marketplace: the explosion of a vigorous and demanding middle class. How does it impact the future directions the industry should pursue?
Mobile technology is changing the way we interact and communicate with each other, but it's yet to pierce the ingrained practices of healthcare. However, mobile health is making headway and creating business models that unlock access to new players and technologies that support preventative, acute and chronic care.
How universities manage innovation through disciplined and novel measures.
To survive the coming storm, biomedical companies must build new models of innovation that are anchored in consumer-centric disease solutions rather than the traditional R&D department approaches.
What are the emerging trends from the employer's perspective on the needs, wants, and satisfaction levels of employers regarding health insurance and benefits?
What is the capacity and capability for medical technology innovation in Brazil, China, France, Germany, India, Israel, Japan, United Kingdom, United States?
This report looks at the factors driving needed change in healthcare payment systems to meet future demands and leverage incentives to positively change behaviour and outcomes.
Healthcare services demand and expectations are rising. With reform on the agenda, PwC looks at the changing role of the health insurer.
On 7 June 2012, PwC will release a report about mobile health (mHealth) with analysis from the Economist Intelligence Unit. This report examines the development of mHealth in ten countries, five developed and five emerging, and the role that various stakeholders — from healthcare payers to physicians and patients — can play in its development.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 1Q 2012 edition focuses on investments in the evolving global hospital sector.
The fourth meeting in our series focused in particular on the challenges faced in emerging economies, highlighting innovative practices and solutions that are transferable from one healthcare system to the next. Healthcare executives and leaders from around the globe will gather in South Africa for this landmark event.
Healthcare CEOs are gloomy about the global economy, but they're diversifying and expanding overseas, showing a more positive outlook for their own organisations.
South East Asia’s evolving health systems are using healthcare public-private partnerships (PPPs) to expand capacity and quality of healthcare in emerging markets.
How we assess value in medical technology is changing. How can countries overcome their weaknesses to develop a system to help medical technology companies thrive?
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? This issue focuses on three compelling investment opportunities across the global healthcare provider market.
How can government and private industry be more accountable for healthcare delivery and financing, and how can they achieve greater efficiency in health spending?
On 15 November, 2011, PwC, in conjunction with sponsoring organisations – Duke-NUS Graduate Medical School Singapore, McGill University and The Nuffield Trust – convened the third in a series of four symposia called Bending the Cost Curve: Emerging International Best Practices.
In partnership with the European Hospital and Healthcare Federation (HOPE), this report explores the strategies European hospitals are undertaking to adapt as health systems shift toward more personalised health delivery and medicine.
PwC, in collaboration with McGill University and The Nuffield Trust, hosted the second symposium of Bending the Cost Curve in Amsterdam. About 30 European healthcare leaders participated in roundtable discussions exploring case studies in: wiring-up healthcare; integrated care; precision medicine; hospital efficiency and regulation of healthcare.
To take advantage of the opportunities that healthcare's new products and services offer, businesses need to build innovative business models to provide value.
On 2 February 2011, PwC, in conjunction with three sponsoring organizations—the Atlantic Council, McGill University and The Commonwealth Fund—launched Bending the Cost Curve: Emerging International Best Practices. The meeting brought together some of the world’s leading healthcare experts who explored five international case studies, debated the issues and left with lessons learned.
There is a major phenomenon in the Chinese healthcare marketplace: the explosion of a vigorous and demanding middle class. How does it impact the future directions the industry should pursue?
Mobile technology is changing the way we interact and communicate with each other, but it's yet to pierce the ingrained practices of healthcare. However, mobile health is making headway and creating business models that unlock access to new players and technologies that support preventative, acute and chronic care.
How universities manage innovation through disciplined and novel measures.
To survive the coming storm, biomedical companies must build new models of innovation that are anchored in consumer-centric disease solutions rather than the traditional R&D department approaches.
What are the emerging trends from the employer's perspective on the needs, wants, and satisfaction levels of employers regarding health insurance and benefits?
What is the capacity and capability for medical technology innovation in Brazil, China, France, Germany, India, Israel, Japan, United Kingdom, United States?
This report looks at the factors driving needed change in healthcare payment systems to meet future demands and leverage incentives to positively change behaviour and outcomes.
Healthcare services demand and expectations are rising. With reform on the agenda, PwC looks at the changing role of the health insurer.
On 7 June 2012, PwC will release a report about mobile health (mHealth) with analysis from the Economist Intelligence Unit. This report examines the development of mHealth in ten countries, five developed and five emerging, and the role that various stakeholders — from healthcare payers to physicians and patients — can play in its development.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 1Q 2012 edition focuses on investments in the evolving global hospital sector.
The fourth meeting in our series focused in particular on the challenges faced in emerging economies, highlighting innovative practices and solutions that are transferable from one healthcare system to the next. Healthcare executives and leaders from around the globe will gather in South Africa for this landmark event.
Healthcare CEOs are gloomy about the global economy, but they're diversifying and expanding overseas, showing a more positive outlook for their own organisations.
South East Asia’s evolving health systems are using healthcare public-private partnerships (PPPs) to expand capacity and quality of healthcare in emerging markets.
How we assess value in medical technology is changing. How can countries overcome their weaknesses to develop a system to help medical technology companies thrive?
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? This issue focuses on three compelling investment opportunities across the global healthcare provider market.
How can government and private industry be more accountable for healthcare delivery and financing, and how can they achieve greater efficiency in health spending?
On 15 November, 2011, PwC, in conjunction with sponsoring organisations – Duke-NUS Graduate Medical School Singapore, McGill University and The Nuffield Trust – convened the third in a series of four symposia called Bending the Cost Curve: Emerging International Best Practices.
In partnership with the European Hospital and Healthcare Federation (HOPE), this report explores the strategies European hospitals are undertaking to adapt as health systems shift toward more personalised health delivery and medicine.
PwC, in collaboration with McGill University and The Nuffield Trust, hosted the second symposium of Bending the Cost Curve in Amsterdam. About 30 European healthcare leaders participated in roundtable discussions exploring case studies in: wiring-up healthcare; integrated care; precision medicine; hospital efficiency and regulation of healthcare.
To take advantage of the opportunities that healthcare's new products and services offer, businesses need to build innovative business models to provide value.
On 2 February 2011, PwC, in conjunction with three sponsoring organizations—the Atlantic Council, McGill University and The Commonwealth Fund—launched Bending the Cost Curve: Emerging International Best Practices. The meeting brought together some of the world’s leading healthcare experts who explored five international case studies, debated the issues and left with lessons learned.
There is a major phenomenon in the Chinese healthcare marketplace: the explosion of a vigorous and demanding middle class. How does it impact the future directions the industry should pursue?
Mobile technology is changing the way we interact and communicate with each other, but it's yet to pierce the ingrained practices of healthcare. However, mobile health is making headway and creating business models that unlock access to new players and technologies that support preventative, acute and chronic care.
How universities manage innovation through disciplined and novel measures.
To survive the coming storm, biomedical companies must build new models of innovation that are anchored in consumer-centric disease solutions rather than the traditional R&D department approaches.
What are the emerging trends from the employer's perspective on the needs, wants, and satisfaction levels of employers regarding health insurance and benefits?
What is the capacity and capability for medical technology innovation in Brazil, China, France, Germany, India, Israel, Japan, United Kingdom, United States?
This report looks at the factors driving needed change in healthcare payment systems to meet future demands and leverage incentives to positively change behaviour and outcomes.
Healthcare services demand and expectations are rising. With reform on the agenda, PwC looks at the changing role of the health insurer.